Aneurysm treatment ranges from careful surveillance with periodic imaging all the way to emergency open surgery, and the right approach depends on where the aneurysm sits, how large it is, whether it has ruptured, and the patient’s overall health. For brain aneurysms, the main options are surgical clipping and endovascular coiling, with newer flow-diverting stents filling a gap for complex cases. For aortic aneurysms, the choice typically falls between open surgical repair and endovascular stent grafting. The field has shifted dramatically toward less invasive techniques over the past two decades, but emerging long-term data suggest the picture is more complicated than “newer equals better.”
Brain Aneurysm Treatments
Cerebral aneurysms are treated primarily through two approaches. Surgical clipping involves opening the skull, exposing the aneurysm, and placing a small metal clip across its neck to stop blood from entering it. Endovascular coiling, by contrast, threads a catheter through the blood vessels (usually starting from the groin) and packs the aneurysm sac with soft platinum coils, prompting blood to clot around them and seal the aneurysm from the inside. Both techniques aim to prevent rupture or, in emergency cases, stop rebleeding after a rupture has already occurred.
The trade-offs between the two have been debated for decades. Coiling tends to produce a smoother short-term recovery, with lower rates of complications immediately after the procedure. A systematic review comparing the two found that clipping achieves higher rates of complete aneurysm occlusion and lower rates of recurrence and retreatment, while coiling is associated with lower immediate morbidity and mortality.1PubMed Central. Surgical Clipping Versus Endovascular Coiling in the Management of Intracranial Aneurysms A meta-analysis looking specifically at long-term durability confirmed this pattern: clipping had better durability overall, with coiling showing a relatively high incidence of recurrence and need for retreatment.2PubMed. Long-Term Durability of Open Surgical versus Endovascular Repair of Intracranial Aneurysms: A Systematic Review and Meta-Analysis
That durability gap has been a persistent source of controversy. Critics of coiling point out that the initial benefit seen in early recovery fades over time, and that functional outcomes between the two approaches eventually converge. Proponents respond that newer coiling technology and techniques have reduced recurrence and rebleeding rates compared with earlier generations of the procedure.3PubMed Central. Clipping versus coiling: A critical re-examination of a decades old controversy A pragmatic randomized trial of unruptured aneurysms found no statistically significant difference in morbidity and mortality at one year between the two groups, though the sample was small.4Journal of Neurology, Neurosurgery & Psychiatry. Surgical clipping or endovascular coiling for unruptured intracranial aneurysms: a pragmatic randomised trial
Interestingly, recurrent bleeding after treatment does not always favor the approach you might expect. One long-term study found that in the first eight years after treatment of ruptured aneurysms, the cumulative incidence of recurrent subarachnoid hemorrhage was lower after coiling (under 1%) than after clipping (about 3%).5PubMed. Long-term recurrent subarachnoid hemorrhage after adequate coiling versus clipping of ruptured intracranial aneurysms The numbers are small in both groups, but they complicate the simple narrative that clipping is always more durable.
Flow Diversion for Complex Cases
Some brain aneurysms are wide-necked, very large, or oddly shaped, making them difficult to treat with either conventional clipping or standard coiling. Flow-diverting stents have transformed the management of these cases. A flow diverter is a tightly woven mesh tube placed inside the parent artery across the aneurysm’s opening. It redirects blood flow away from the aneurysm sac, encouraging the aneurysm to clot and eventually shrink while keeping the artery itself open.6PubMed Central. Flow Diversion for Intracranial Aneurysm Management: A New Standard of Care
Early clinical experience showed that flow diversion could effectively treat large and giant aneurysms with acceptable complication rates.7PubMed. Flow diversion for intracranial aneurysms: a review This represented a genuine advance, because previously many of these complex aneurysms were considered untreatable or required risky multi-stage procedures. Balloon-assisted and stent-assisted coiling techniques had already expanded the range of treatable aneurysms, but flow diversion added another tier of capability.8PubMed. Brain aneurysms and arteriovenous malformations: advancements and emerging treatments in endovascular embolization Flow diverters do require patients to take blood thinners afterward to prevent clotting on the stent, which introduces its own risks, particularly if the patient has a ruptured aneurysm or needs another surgical procedure in the near term.
Aortic Aneurysm Repair
The treatment landscape for abdominal aortic aneurysms mirrors the brain aneurysm story in some ways: an older, more invasive open surgical technique exists alongside a newer, less invasive endovascular option, and the debate over which serves patients better long-term is far from settled.
Open repair involves a large abdominal incision. The surgeon clamps the aorta above and below the aneurysm, opens it, and sews in a synthetic graft to replace the weakened section. The operation is major, with a longer hospital stay and recovery, but the repair is mechanically straightforward and durable. Endovascular aneurysm repair, known as EVAR, threads a stent graft through the femoral artery and anchors it inside the aorta, excluding the aneurysm from blood flow without opening the abdomen.
Randomized trials have consistently shown that EVAR has a lower risk of dying in the first month or so after the procedure. But that early survival advantage fades. A large randomized trial found no significant difference in overall mortality between the two approaches over long-term follow-up. Survival appeared to favor EVAR in the first four years, then shifted toward open repair through year eight, and then shifted again, though none of these trends reached statistical significance.9PubMed. Open versus Endovascular Repair of Abdominal Aortic Aneurysm A matched analysis from a Medicare database told a somewhat different story: after propensity-score matching, patients who had open repair had significantly lower long-term rates of death, rupture, and reintervention than those who had EVAR.10JAMA Network Open. Long-term Outcomes Associated With Open vs Endovascular Abdominal Aortic Aneurysm Repair in a Medicare-Matched Database
For very high-risk patients who might not survive open surgery, EVAR offers a clear advantage. An earlier propensity-adjusted study found that in the sickest surgical patients, 30-day mortality was roughly 5% with EVAR compared with about 19% with open surgery.11PubMed. Endovascular stent grafting versus open surgical operation in patients with infrarenal aortic aneurysms: a propensity score-adjusted analysis The practical upshot: EVAR is often the better choice for older or frailer patients who need the aneurysm fixed but may not tolerate a big operation, while younger, healthier patients may benefit from open repair’s greater long-term durability.
Endoleaks and the Hidden Cost of EVAR
One complication almost unique to endovascular repair is the endoleak, where blood continues to flow into the aneurysm sac around or through the stent graft. Endoleaks are classified by where the leak originates and can range from harmless to dangerous. Early classification work found that most endoleaks detected immediately after surgery came from the area where the graft attached to the aorta (the proximal end), and the majority were persistent rather than self-sealing.12PubMed. Endoleaks after endovascular graft treatment of aortic aneurysms: classification, risk factors, and outcome Some types resolve on their own; others require additional procedures to seal. This need for ongoing surveillance imaging and potential reintervention is one reason EVAR’s long-term costs can exceed those of open repair, even though the initial hospital stay is shorter.
When to Fix It and When to Watch
Not every aneurysm needs treatment right away. The decision to intervene balances the risk of the aneurysm rupturing against the risk of the repair itself. For abdominal aortic aneurysms, the Society for Vascular Surgery recommends elective repair when a fusiform aneurysm reaches 5.5 cm in a patient at acceptable surgical risk, with a lower threshold of 5.0 to 5.4 cm for women.13Journal of Vascular Surgery. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm These thresholds are widely used, but they are averages, not universal truths.
A recent modeling study suggested the optimal repair size may actually be larger than current guidelines recommend. For a 60-year-old woman in average health, the model found that repairing at about 6.1 cm minimized aneurysm-related mortality, and for a 60-year-old man, the optimal size was roughly 6.9 cm.14PubMed Central. Article size thresholds for repair of abdominal aortic aneurysms warrant reconsideration These findings matter because a surprising proportion of repairs in practice happen below guideline thresholds. A study of the Vascular Quality Initiative database found that nearly 40% of endovascular repairs were performed on aneurysms smaller than what guidelines recommended. Among those patients who were also at high physiologic risk, one-year survival was worse than for lower-risk patients treated within guidelines.15PubMed. Contemporary trends in elective endovascular aortic repair and compliance with Society for Vascular Surgery clinical practice guidelines In other words, operating too early on small aneurysms in sick patients may cause more harm than it prevents.
For brain aneurysms, the calculation is different because the consequences of rupture are so severe, often fatal or permanently disabling. The PHASES score was developed to help predict the five-year risk of rupture for unruptured intracranial aneurysms, based on factors like aneurysm size, location, patient age, and history of prior hemorrhage.16PubMed. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies It is useful but imperfect. A retrospective study of patients who actually did rupture found that nearly 80% of them would have been scored at less than 2% five-year rupture risk, suggesting the tool may underestimate danger in many cases.17PubMed. The PHASES score: To treat or not to treat? Retrospective evaluation of the risk of rupture of intracranial aneurysms in patients with aneurysmal subarachnoid hemorrhage The score also performs worse for small aneurysms specifically.18PubMed. Evaluation of PHASES Score for Predicting Rupture of Intracranial Aneurysms: Significance of Aneurysm Size Clinicians still use the PHASES score, but typically alongside clinical judgment, anatomic details, and patient preferences rather than as a standalone decision tool.
Slowing Growth Without Surgery
For aortic aneurysms that are too small to warrant repair, the standard approach is surveillance imaging every six to twelve months plus aggressive management of cardiovascular risk factors. Smoking is the single most modifiable accelerator of aneurysm growth: quitting slows expansion, and continuing speeds it up.19JAMA Surgery. Factors Associated With Small Abdominal Aortic Aneurysm Expansion Rate
There is growing interest in whether common medications can slow aneurysm expansion. The UK Aneurysm Growth Study found that metformin was strongly associated with slower growth, reducing expansion by nearly 0.4 mm per year on average compared with patients not on the drug. ACE inhibitors and a related class of blood pressure medications showed a similar effect, while current smoking increased growth by about 0.3 mm per year.20British Journal of Surgery. Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study These are observational associations, not proof of causation, and randomized trials are needed before any of these drugs can be recommended specifically for aneurysm management. Still, many patients with aortic aneurysms already have diabetes or high blood pressure, so these findings suggest their existing prescriptions may be doing double duty.
On the research frontier, scientists have identified hundreds of potential drug targets for stabilizing aneurysm walls, mostly aimed at calming the inflammatory and tissue-degrading processes that weaken the aorta.21PubMed Central. Pharmacologic Management of Aneurysms One experimental approach used nanoparticles loaded with an enzyme-blocking drug and targeted them to the damaged elastin in aneurysm walls. In an animal model, the treatment substantially suppressed aneurysm expansion, preserved the elastic structure of the vessel wall, and reduced inflammation compared with untreated controls.22PubMed Central. Prevention of Abdominal Aortic Aneurysm Progression by Targeted Inhibition of Matrix Metalloproteinase Activity with Batimastat-Loaded Nanoparticles No drug has yet made it to routine clinical use for stopping aneurysm growth, but the research pipeline is active.
Fenestrated and Branched Grafts for Complex Aortic Aneurysms
Standard endovascular stent grafts need a stretch of normal aorta above and below the aneurysm to anchor properly. When the aneurysm extends up near the arteries that supply the kidneys, gut, or spinal cord, the standard approach does not work. This is where fenestrated and branched endografts come in. These custom-made devices have holes (fenestrations) or side arms (branches) that align with the critical artery openings, allowing the graft to seal off the aneurysm while preserving blood flow to vital organs.
The technology has extended endovascular repair to thoracoabdominal aortic aneurysms that previously required extensive open surgery with high complication rates.23Journal of Vascular Surgery. Fenestrated and branched endovascular aneurysm repair outcomes for type II and III thoracoabdominal aortic aneurysms Midterm follow-up data from a prospective study found that fenestrated-branched repair was safe and effective for both pararenal and thoracoabdominal aneurysms, with low rates of aneurysm-related death and rupture.24Annals of Surgery. Midterm Outcomes of a Prospective, Nonrandomized Study to Evaluate Endovascular Repair of Complex Aortic Aneurysms Using Fenestrated-Branched Endografts These procedures are technically demanding and currently performed at specialized centers, but they represent one of the fastest-evolving areas in vascular surgery.
Screening and Catching Aneurysms Early
Most aortic aneurysms produce no symptoms until they rupture, which makes screening programs important. A simple ultrasound of the abdomen can reliably detect an aneurysm, and long-term data from the UK’s Multicentre Aneurysm Screening Study showed that inviting men aged 65 to 74 for a one-time ultrasound reduced aneurysm-related death by about 48% over ten years. The program also became more cost-effective over time.25BMJ. Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study Several countries now offer population-based screening for men at age 65, though screening for women remains debated because aortic aneurysms are less common in women, even though they tend to rupture at smaller diameters.26PubMed Central. Ultrasound screening for abdominal aortic aneurysm
Brain aneurysms are a different story. There is no population-wide screening program because the vast majority of small, unruptured intracranial aneurysms will never cause problems, and finding them can lead to anxiety, unnecessary treatment, or both. Screening is generally reserved for people at elevated risk, such as those with two or more first-degree relatives who have had brain aneurysms, or those with connective tissue disorders like Marfan syndrome, Ehlers-Danlos syndrome, or Loeys-Dietz syndrome.27PubMed Central. Aortic disease in the young: genetic aneurysm syndromes, connective tissue disorders, and familial aortic aneurysms and dissections These inherited conditions affect the structural proteins in blood vessel walls, making them prone to dilation and rupture at younger ages.28PubMed Central. Thoracoabdominal aortic aneurysm in connective tissue disorder patients
Why Aneurysms Form and Why That Matters for Treatment
Understanding what goes wrong in the vessel wall helps explain why current treatments work the way they do and why a true “cure” remains elusive. The key structural protein involved is elastin, which gives arteries their ability to stretch and recoil with every heartbeat. In an aneurysm, elastin breaks down progressively, and the body is very bad at replacing it. Less than 1% of the body’s total elastin turns over in a year, which means once damage is done, it is essentially permanent.29PubMed Central. Elastin in the Pathogenesis of Abdominal Aortic Aneurysm The ongoing breakdown of structural proteins, particularly in the middle layer of the artery wall, is what eventually leaves the vessel unable to withstand normal blood pressure.30PubMed. In vivo assessment of aortic aneurysm wall integrity using elastin-specific molecular magnetic resonance imaging
As elastin degrades, the artery’s mechanical behavior changes. Research using chemical degradation models has shown that gradual loss of elastin leads to a progression through different mechanical states, with a potential transition stage that may accelerate dilation once a critical threshold of damage is reached.31PubMed Central. Progressive structural and biomechanical changes in elastin degraded aorta This is one reason aneurysm growth can seem stable for years and then suddenly accelerate. It also explains why all current treatments, whether surgical clips, coils, or stent grafts, work by mechanically bypassing the weakened wall rather than restoring it. No existing treatment regenerates lost elastin.
Vasospasm After Rupture
When a brain aneurysm ruptures, the immediate bleeding is only part of the danger. In the days following subarachnoid hemorrhage, the blood vessels near the rupture site can go into spasm, narrowing dramatically and starving brain tissue of oxygen. This vasospasm is a major cause of disability and death even after the ruptured aneurysm itself has been secured. Treating or preventing it has been a major focus of neurocritical care research. Clazosentan, a drug that blocks a receptor involved in blood vessel constriction, showed promise in early trials and was tested in large phase 3 studies aimed at reducing vasospasm-related harm after subarachnoid hemorrhage.32PubMed. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials The results were mixed, and vasospasm management remains one of the harder problems in post-rupture care.
Machine Learning and Rupture Prediction
One of the most active areas of research is using artificial intelligence to predict which aneurysms are likely to rupture. Traditional risk scores like PHASES rely on a handful of clinical and anatomic variables. Machine learning models can incorporate more information, including the shape of the aneurysm and the way blood flows through it, as computed by fluid dynamics simulations. One study using a random forest algorithm on 226 cerebral aneurysms achieved about 78% accuracy in classifying ruptured versus unruptured status using a combination of shape measurements and blood flow patterns.33PubMed Central. Machine Learning Classification of Cerebral Aneurysm Rupture Status with Morphologic Variables and Hemodynamic Parameters Another study using a different algorithm on a smaller sample of 60 aneurysms reported even higher discrimination.34Journal of Mechanics in Medicine and Biology. Computational Study on the Rupture Risk in Real Cerebral Aneurysms with Geometrical and Fluid-Mechanical Parameters Using FSI Simulations and Machine Learning Algorithms
These models are still research tools, not clinical decision-makers. But the direction is clear: the goal is to move beyond simple size cutoffs and toward individualized risk profiles that account for each aneurysm’s unique geometry and hemodynamics. If these tools mature, they could help identify the small aneurysms that current scoring systems tend to dismiss but that occasionally rupture with devastating consequences.
Life After Treatment
Something that gets less attention than it deserves is what happens to patients psychologically after aneurysm treatment, particularly for brain aneurysms. A study of patients treated for incidental, unruptured intracranial aneurysms found that many reported a relatively low quality of life afterward, with limitations in their ability to work or carry out daily activities due to perceived physical or mental handicaps. There was no significant difference in quality-of-life scores between patients who had clipping and those who had coiling, and scores did not improve over time.35PubMed. Quality of life after treatment for incidental, unruptured intracranial aneurysms The finding is striking because these were aneurysms found by accident, not after a bleed, and the patients’ functional outcomes were generally good. The psychological burden of knowing you had a brain aneurysm, going through a procedure, and living with the worry of recurrence appears to take its own toll.
For patients who survive a ruptured aneurysm, the picture can be bleaker. One study found that more than half of survivors experienced depression, and a similar proportion had measurable cognitive impairment. Those with depression had dramatically worse quality-of-life scores.36PubMed Central. Cognitive function, depression, and quality of life in patients with ruptured cerebral aneurysms These outcomes reinforce why the treatment decision for unruptured aneurysms is so agonizing: you are weighing the risk of a catastrophic bleed against the real costs of intervention, which include not just surgical complications but long-lasting changes in how patients feel about their own bodies and futures.